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Abstract
Background:  The purpose of this study was to identify mutations associated with bilateral
retinoblastoma in a quadruplet conceived by in vitro fertilization, and to trace the parental origin
of mutations in the four quadruplets and their father.
Methods: Mutational screening was carried out by sequencing. Genotyping was carried out for
determining quadruplet zygosity.
Results: The proband was a carrier of a novel RB1 constitutive mutation (g.2056C>G) which was
not detected in her father or her unaffected sisters, and of two other mutations (g.39606 C>T and
g.174351T>A) also present in two monozygotic sisters. The novel mutation probably occurred de
novo while the others were of likely maternal origin. The novel mutation, affecting the Kozak
consensus at the 5'UTR of RB1 and g.174351T>A were likely associated to retinoblastoma in the
proband.
Conclusion: Molecular diagnosis of retinoblastoma requires genotypic data of the family for
determining hereditary transmission. In the case of children generated by IVF with oocytes from an
anonymous donor which had been stored in a cell repository, this might not be successfully
accomplished, making precise diagnosis impracticable for genetic counseling.
Background
Retinoblastoma (RB; MIM #180200) is the most common
intraocular pediatric tumor, with an incidence of 1/
15,000–25,000 live births. It results from mutational
inactivation of both alleles of the tumor suppressor RB1
gene that encodes a nuclear phosphoprotein (pRB)
involved in the control cell cycle [1-3]. In the hereditary
form, accounting for 40% of RB patients, an RB1 germline
mutation is transmitted as an autosomal dominant trait
with high penetrance (90%), resulting in a 45% risk of
occurrence in the offspring, with increased risk for second-
ary malignancies. In the sporadic form, mutational inacti-
vation of both RB1 alleles arises from somatic events in
retinal cells, without germline alterations [4].
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Genetic alterations frequently resulting from RB1 inacti-
vation involve chromosome rearrangements affecting the
13q14 region (deletion, translocation), nucleotide
changes (substitutions, deletions, insertions and duplica-
tions), exonic deletions (single or multiple); loss of heter-
ozygosity [5], or CpG island hypermethylation of the RB1
promoter region [6]. Epigenetic mechanisms playing a
role in some RB patients include differential methylation
of chromosome 13q around RB1 [7] and preferential loss
of maternal alleles in sporadic cases, suggesting a latent
imprinting [8].
Identification of RB1 mutations in hereditary RB provides
accurate risk prediction and valuable genetic counseling
for patients and their families. Furthermore, the nature of
a mutation can determine genetic penetrance, disease
presentation and prognosis [9].
Recent investigations suggest an apparent association
between in vitro fertilization (IVF) and genetic syndromes,
including retinoblastoma [8]. It has been postulated that
embryos in culture may acquire epigenetic defects as a
result of abnormal environmental conditions which may
lead to aberrant phenotypes. These studies illustrated a
complex problem involving legal and ethical aspects and
privacy protection in the field of assisted reproductive
technologies (ART), with potential implications in the
genetic counseling of retinoblastoma.
We herein describe a novel constitutive mutation at the 5'
UTR of RB1 in a patient with bilateral retinoblastoma,
who also carried two other constitutive mutations also
present in two of her sisters conceived by IVF.
Methods
Patients and samples
We studied a family of female quadruplets (A, B, C and D)
conceived by IVF of oocytes from one anonymous donor
with sperm of their father. One quadruplet presented
bilateral retinoblastoma diagnosed by current ophthal-
mological and histopathological criteria at one month of
age. The proband (A) was referred to the Genetic Coun-
seling Program of the Instituto Nacional de Cancer (Rio
de Janeiro, Brazil) and subsequently selected for muta-
tional screening, together with her three sisters and their
father. All quadruplets have been followed by periodical
ophthalmological examinations to present.
Blood samples were obtained from the quadruplets and
their father. Samples and information on the family were
obtained with an informed consent. Tumor samples were
not available for analysis. With respect to privacy and ano-
nymity required for IVF, blood samples could not be
obtained from the female donor. This study was approved
by local Ethics Committee and followed the tenents and
guidelines of the Declaration of Helsinki.
Mutation screening
RB1 exons 2–27 were PCR-amplified in individual reac-
tions containing 100 ng DNA, 0.4 pm of each primer [for-
ward and reverse previously reported [5]], 0.15 mM of
each dNTP, 3 mM MgCl2, 1× PCR buffer (Promega Corpo-
ration, Madison, Wisconsin, USA) and 1 U of Taq DNA
polymerase (Promega Corporation) in 50 μl reactions.
PCR was performed with 40 cycles at 94°C (1 min), 54°C
(40 sec) and 72°C (35 sec) in a programmable thermocy-
cler (PT-100; MJ Research, Inc., Waltham, Massachussets,
USA). Reaction mixes were prepared as previously
described [5], with Taq DNA Polymerase, Recombinant
(Invitrogen, Carlsbad, California, USA). PCR conditions
were 40 cycles at 94°C (1 min), 49°C (40 sec) and 72°C
(35 sec), in a programmable thermocycler (PT-100; MJ
Research, Inc.).
RB1 promoter region and exon 1 analysis
Forward 5'-GGTTTTTCTCAGGGGACGTT-3' and reverse
5'-AACCCAGAATCCTGTCACCA-3' primers were used to
amplify the RB1  promoter and exon 1 from genomic
DNA. Reaction mixes were prepared containing 100 ng
DNA, 0.4 pm of each primer (forward and reverse), 5%
DMSO, 0.15 mM of each dNTP, 3 mM MgCl2, 1× PCR
buffer (Promega Corporation, Madison, Wisconsin, USA)
and 1 U of Platinum Taq DNA polymerase (Promega Cor-
poration) in 50 μl reactions. PCR was performed with 40
cycles at 94°C (1 min), 50°C (40 sec) and 72°C (45 sec)
in a programmable thermocycler (PT-100; MJ Research,
Inc., Waltham, Massachussets, USA).
RNA was extracted from blood cells of the proband iso-
lated with Ficoll-Paque PLUS® (GE Healthcare UK, Little
Chalfont, UK) using TRIZOL® (Invitrogen Corporation,
California, USA) following the specifications of the man-
ufacturer and cDNA was synthesized with SuperScript
First-Strand Synthesis System for RT-PCR (Invitrogen Cor-
poration, California, USA).
A cDNA region, including part of the 5' UTR of RB1, was
amplified using the forward primer 5'-CTCCCCG-
GCGCTCCTCCACAGC-3' annealing downstream of tran-
scription start sites -176 and -128 [10] and the reverse
primer 5'-AGAACACCACGAAAAAGTAA-3' annealing in
exon 6. Reaction mixes contained 100 ng cDNA, 0.4 pm
of each primer, 5% DMSO, 0.15 mM of each dNTP, 3 mM
MgCl2, 1× PCR buffer (Promega Corporation, Madison,
Wisconsin, USA) and 1 U of Platinum Taq DNA polymer-
ase (Promega Corporation) in 50 μl reactions. PCR was
performed with 50 cycles at 94°C (1 min), 55°C (40 sec)
and 72°C (1 min) in a programmable thermocycler (PT-
100; MJ Research, Inc., Waltham, Massachussets, USA).
Amplified products were electrophoresed in 2% agarose
gels with ethidium bromide. Direct sequencing was per-
formed with an ABI PRISM 377 automatic DNA sequencerBMC Medical Genetics 2009, 10:75 http://www.biomedcentral.com/1471-2350/10/75
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(Applied Biosystems, Foster City, California, USA).
Sequences were analyzed using Sequencher TM Demo
Version 4.1.4 software (Gene Codes Corporation 2005 –
775 Technology Drive, Ann Arbor, Michigan, USA) and
compared to a reference sequence (Genbank accession
L11910.1). Constitutive alterations identified in this
study were compared with those published in RB1 gene
mutation database-Retinoblastoma Genetics website
(available at http://www.verandi.de/joomla/index.php).
Diagnosis of zygosity
Genotyping was carried out with PowerPlexTM16 System
(Promega Corporation), following the recommendations
of the manufacturer, for identifying quadruplet zygosity.
This assay comprised multiplex PCR amplifications of 15
STR loci, including D13S317 (a microsatellite marker
located at 13q22-q31). An additional microsatellite flan-
kling RB1 (D13S284 located at 13q14.3) was also used for
genotyping.
Results
Fundoscopic analysis identified a bilateral retinoblastoma
in one child (A) while the three other quadruplets and
their father showed a normal fundoscopy. Mutational
screening in the proband detected three constitutive alter-
ations, one consisting of a transversion in intron 25
(g.174351T>A), previously reported [11,12], and a transi-
tion in intron 3 (g.39606 C>T), previously described [7].
Both mutations were also present in quadruplets C and D
but were absent in B and their father (Figure 1). A third
mutation consisted of a novel transversion at the 5' UTR
of the RB1 promoter, in position – 4 (g.2056C>G) with
respect to the initial ATG codon. This mutation was not
detected in her father or the three other quadruplets. Anal-
ysis of the proband's cDNA showed a clear electrophero-
gram showing only the g.2056C allele (Figure 1).
Genotyping showed that the quadruplets had originated
from three trizygotic embryos, one corresponding to A, a
second one to B, and a third one to the monozygotic twins
C and D. One 13q marker (D13S317) included in the
PowerPlex 16 system showed two paternal alleles (11 pb
and 12 pb), and one maternal allele (9 pb) that was
present in all quadruplets (Table 1). These results were
confirmed by D13S284, with two paternal alleles (213 pb
and 215 pb) and two maternal alleles (205 pb and 213
pb; see Table 2).
Discussion
Several clinical reports have suggested an association
between assisted reproduction technologies (ART) and
increased risk of genetic disorders including retinoblast-
1. Partial sequence of 5' UTR of RB1 in genomic DNA showing a C>G mutation (indicated by arrow) in position -4 with  respect to the initial translation ATG codon in proband (A) Figure 1
1. Partial sequence of 5' UTR of RB1 in genomic DNA showing a C>G mutation (indicated by arrow) in posi-
tion -4 with respect to the initial translation ATG codon in proband (A). This alteration was not detected in the 
father or in other quadruplets (B, C and D). 2. Partial sequence of intron 3 in genomic DNA showing a C>T transition (indi-
cated by arrow) in proband A and in two monozygotic sisters (C and D). This transition was absent in the father and B. 3. Par-
tial sequence of intron 25 in genomic DNA showing a T>A transversion (indicated by arrow) in the proband A and two 
monozygotic sisters C and D. This transversion was absent in the father and quadruplet B. 4. Partial sequence of 5' UTR of RB1 
in cDNA of proband's leukocytes showing only the g.2056C allele.
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oma, in children conceived with the use of ART. These
might be a consequence of accumulation of epigenetic
alterations during embryo culture and/or alteration of
developmental timing. In some cases of retinoblastoma,
RB1 was epigenetically silenced by hypermethylation at
the promoter region, resulting in reduced RB1 expression.
Since tumor material was not available, peripheral assess-
ment of methylation of the RB1 promoter in leukocytes
would not have been informative because the dynamics of
DNA methylation in primary tumor tissues are clearly dif-
ferent from normal cells, and not confined to specific CpG
sites [13].
RB1 patterns and haplotypes
Genotypic analysis of 13q was carried out with three intra-
genic RB1 alleles and two microsatellites closely linked to
RB1. Presumably, transmission of intragenic alleles
occurred without recombination, corresponding to paren-
tal RB1 patterns [C-C-T] and [C-T-A]. Conversely, the pos-
sibility of recombination might have occurred between
RB1, D13S284 and D13S317.
The putative paternal haplotypes were [C-C-T]-213-11
and [C-C-T]-215-12, and the likely maternal haplotypes
were [C-T-A]-213-9 and [C-C-T]-205-9. The mother could
be a 9/9 homozygous for D13S317 or, alternatively, [C-C-
T]-205-9 was a recombinant haplotype, in view that 213-
9 cosegregation was more frequent than 205-9.
Parental origin of mutations
The father was found to be a C/C homozygote at g.2056,
while genotypic data indicated that the mother was also a
C/C homozygote. Thus, g.2056C>G was not constitu-
tional in the proband's progenitors and could have
occurred either in the maternal or the paternal RB1 allele,
as a de novo event in germ lines or in the zygote.
Table 1: Genotyping of four quadruplets and father.
Locus Father Proband (A) Sister (B) Sister (C) Sister (D) Deduced maternal alleles
D3S1358 14–18 17–18 14–17 14–17 14–17 17–?
TH01 7–8 7–9 7–9.3 8–9.3 8–9.3 9–9.3
D21S11 28–29 28–31 29–31 28–31 28–31 31 – ?
D18S51 14–15 14–15 14–15 14–15 14–15 14? – or 15?
PENTA E 13–15 13–15 5–13 13–15 13–15 5 – ?
D5S818 12–12 12–13 12–12 12–13 12–13 12–13
D13S317 11–12 9–11 9–12 9–12 9–12 9 – ?
D7S820 11–12 11–12 11–11 11–12 11–12 11–?
D16S539 8–9 8–12 9–12 9–9 9–9 9–12
CSF1PO 10–12 10–11 10–12 10–10 10–10 11–10
PENTA D 2.2–10 10–13 10–13 2.2–13 2.2–13 13 – ?
VWA 16–16 16–16 13–16 13–16 13–16 13–16
D8S1179 11–13 11–13 9–11 13–13 13–13 9–13
TPOX 8–11 8–11 11–11 8–11 8–11 11 – ?
FGA 21–25 21–21 21–21 21–21 21–21 21–?
AMEL X-Y X-X X-X X-X X-X
? = unknown allele
Analysis of 16 molecular markers used for genotyping quadruplets and their father. Numbers represent alleles identified with PowerPlex 16 
System®. Maternal alleles were deduced. The Amelogenin marker (AMEL) was used as an X chromosome marker. Genotyping allowed for the 
diagnosis of zygosity in the quadruplets.BMC Medical Genetics 2009, 10:75 http://www.biomedcentral.com/1471-2350/10/75
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Alternatively, haplotypic data indicated that g.2056C>G
could have occurred in the maternal RB1 allele because
the expected paternal haplotype was [C-C-T]-213-11 and
the expected maternal haplotype was [C-T-A]-213-9. A
putative paternal haplotype, identical with the expected
one, could be deduced in the proband, together with a
putative maternal [G-T-A]-213-9 haplotype derived from
the expected maternal haplotype.
Genotypic analysis indicated that both g.39606T and
g.174351A alleles were of maternal origin because they
were not present in the father. They were present in three
quadruplets derived from two different embryos (A, C and
D). Moreover, in the proband, in whom the paternal hap-
lotype [C-C-T]-213-11 was deduced, these two mutations
must have co-segregated with the maternal 213-9 alleles
as was the case of quadruplets C and D. Moreover, the fact
that child B did not carry these alleles ruled out the possi-
bility of co-segregation with the paternal alleles 215-12 in
B, C and D (Table 2).
Association of mutations with retinoblastoma
We identified a novel constitutive mutation in the 5' UTR
of the RB1 promoter region (g.2056C>G), in position – 4
with respect to the initial translation ATG codon in an
infant, born after IVF, and affected with bilateral retino-
blastoma. Mutations that weaken adherence to the Kozak
consensus sequence in the 5'UTR have been found to neg-
atively affect translation initiation. In eukaryotes,
sequences flanking the AUG codon modulate their ability
to halt scanning of the 40S ribosomal subunit and to ini-
tiate translation [14]. Translational efficiency was not
herein analyzed, but Cs in these positions are highly con-
served, being part of the consensus reference. This was
confirmed by extensive analysis of Genbank data from
5'UTR sequences of some 700 vertebrate mRNAs [15].
Tumor samples were not available for analysis, a reason
why studies of RB1 expression were not carried out with
this material. cDNA analysis of blood RNA of the
proband, however, indicated that only the g.2056C allele,
in position -4 and located in the 5' UTR of RB1, was
expressed, with an apparent null expression of the
g.2056G allele.
Mutations detected in intron 3 (g.39606C>T) and intron
25 (g.174351T>A) in the proband and her two sisters (C
and D) are less likely to be associated to retinoblastoma
than g.2056C>G. The g.39606C>T mutation has been
considered to be polymorphic [7] while g.174351T>A was
also present as a polymorphic trait in unaffected individ-
uals, with a frequency of 0.70 for the g.174351T allele and
0.30 for the g.174351A allele [12]. Conversely,
g.174351T>A was associated to bilateral retinoblastoma
in one patient in whom this mutation was constitutional
and the only alteration to which retinoblastoma could be
associated [11]. Interestingly, we also found this mutation
as the only alteration in seven patients with retinoblast-
oma (Barbosa et al., unpublished data), a finding suggest-
ing that g.174351T>A might be associated to
development of retinoblastoma. Furthermore, the fact
that g.174351T>A was also found in the unaffected quad-
ruplets C and D does not exclude the possibility of retin-
oblastoma at older age.
Genetic counseling and in vitro fertilization
In this study, retinoblastoma was detected in the proband
at one month of age, a reason why the possibility of tumor
development could not be excluded in her sisters. This is
especially relevant for the monozygotic infants C and D
who carried g.39606C>T and g.174351T>A and who must
be followed by serial fundoscopic analyses. These muta-
tions might be associated to retinoblastoma in view of
previous reports and our unpublished observations.
Table 2: Genotyping of quadruplets and father with respect to mutations and 13q markers.
Mutation/marker Alleles
Father A (proband) B C D
g.2056C>G (in – 4 position in 5'UTR) C/C G/C C/C C/C C/C
g.39606C>T (in intron 3) C/C T/C C/C T/C T/C
g.174351T>A (in intron 25) T/T A/T T/T A/T A/T
D13S284 213/215 213/213 205/215 213/215 213/215
D13S317 11/12 9/11 9/12 9/12 9/12
D13S284 showed two paternal alleles (213 pb and 215 pb) and two maternal alleles (205 pb and 213 pb). The maternal allele 213 pb is present with 
g.2056G in the proband (A), with g.39606T and with g.174351A in quadruplets A, C and D. Paternal alleles in the quadruplets are indicated in bold 
characters.BMC Medical Genetics 2009, 10:75 http://www.biomedcentral.com/1471-2350/10/75
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With respect to IVF, the direct physical manipulation of
gametes and embryos in the ex vivo environment might
result in the appearance de novo point mutations resulting
in the majority of genetic diseases in humans. Moreover,
in a study of mouse embryos showed that genetic altera-
tions in culture conditions might have considerable
impact on the quality of embryos derived by ART [16].
Conclusion
These results have implications for genetic counseling.
Recurrent transmissions or potential transmissions of
Mendelian disorders through the same gamete donor
have been reported in ART [17]-[18] and constitutive RB1
mutations may appear de novo or be transmitted by one
progenitor [4]. For establishing an accurate molecular
diagnosis of retinoblastoma, genotypic data are necessary,
mainly for distinguishing between hereditary from spo-
radic retinoblastoma. In this case, in which blood samples
from the oocyte donor was not available, hereditary retin-
oblastoma could not be proven.
In ART, occurrence or risk of occurrence of a genetic disor-
der in the family must be calculated. Medical, family and
reproductive histories of female and male donors must be
obtained, and appropriate genetic counseling should be
offered and genetic testing implemented [4]. These
requirements cannot be met if the anonymity of gamete
donors were to be respected with all ethical, legal, and
psychological implications, thus making impracticable a
precise diagnosis for genetic counseling. Our finding
requires further research to confirm the association
between IVF and retinoblastoma and to explore likely
causal mechanisms.
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